ORCHPHARMA / NSE / Biotechnology & Drugs
Orchid Pharma
1Y Price Trend
Key Information
Recommendations
RatingStrong Buy
Target High1,120
Target Low471.3
Target Mean1
Target Median0
Risk Metrics
Overall RiskHigh risk
Board Risk46.45
Key Analysis
Overall score, performance score, return rating, defensive, aggressive, and balanced views.
Download appProjection Analytics
Best-case, base-case, worst-case, and dynamic AI projection views.
Download appLatest stock news
Big Pharma is vacating infectious diseases research to chase more lucrative segments like oncology and diabetes. This has left behind a gaping void. A set of Indian companies are diving in—Wockhardt, Orchid Pharma and Bugworks. A successful antibiotic drug can change their fortunes.
Here are a few stocks likely to be in focus on Tuesday, August 13:
Bagadia, executive director at Choice Broking, said some stocks that saw fresh breakouts last Friday were still looking positive on the technical chart and recommended them for intraday trading.
Orchid Pharma recently made headlines for securing US FDA approval for a new drug
Despite an over 86 percent gain in the stock in 2023 YTD, domestic brokerage house Investec sees pharma firm Orchid Pharma (ORCD) rising another 23 percent in the next 12 months. The brokerage has initiated coverage on the stock with a ‘buy’ call and a target price of ₹ 800.
Stock market today: Orchid Pharma's share price hits new 52-week high as the drugmaker launches Qualified Institutional Placement issuance to raise capital.
Stock FAQs
What is the symbol and ISIN of Orchid Pharma?
Orchid Pharma has the symbol ORCHPHARMA and ISIN - INE191A01027.
What is the current price of Orchid Pharma?
Orchid Pharma is currently trading at INR 1,041.35.
What are the year high and year low of Orchid Pharma?
Orchid Pharma has a year high of INR 1,120.00 and a year low of INR 471.30.
What is the market capitalization of Orchid Pharma?
Orchid Pharma has a market capitalization of INR 5,248.34 crore.
What is the P/E ratio of Orchid Pharma?
Orchid Pharma has a P/E ratio of 122.18.
What is the dividend yield of Orchid Pharma?
Orchid Pharma has a dividend yield of 0.00%.
How is the financial performance of Orchid Pharma based on revenue, net income, and EPS?
Orchid Pharma has revenue of INR 8,113.27 crore, net income of INR 205.47 crore, and EPS of INR 5.25.
What is the book value of Orchid Pharma?
Orchid Pharma has a book value of INR 239.38.
What is the debt-to-equity ratio of Orchid Pharma?
Orchid Pharma has a debt-to-equity ratio of NA.
What are the price-to-book and price-to-sales ratios of Orchid Pharma?
Orchid Pharma has a price-to-book ratio of 4.35 and a price-to-sales ratio of 0.65.
© SharekeyX | Rusaka Technologies 2024-2026